Spyre Therapeutics Inc. (SYRE)
undefined
undefined%
At close: undefined
24.12
0.12%
After-hours Dec 13, 2024, 04:15 PM EST

Spyre Therapeutics Inc. Forcast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for SYRE stock have an median target of 49.5, with a low estimate of 40 and a high estimate of 65. The median target predicts an increase of 105.48% from the current stock price of 24.09.

Analyst Consensus: Buy
Target Low Average Median High
Price $40 $51.5 $49.5 $65
Change 66.04% 113.78% 105.48% 169.82%

AI Analyst Report

Stifel reiterated a Buy rating for Spyre Therapeut... Unlock content with Pro Subscription

Updated Mar 26, 2024

Rating May 24Jul 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 100100
Buy 211010
Hold 000001
Sell 000000
Strong Sell 000000
Total 3 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
2.86M
from 886.00K
Increased by 222.5%
Revenue Next Year
4.29M
from 2.86M
Increased by 50.0%
EPS This Year
-3.64
from -49.12
Increased by 92.6%
EPS Next Year
-3.56
from -3.64
Increased by 2.2%